| 08:00 – 09:00 |
Canadian Lung Cancer Conference Breakfast |
| 09:05 – 09:10 |
Welcome to the Canadian Lung Cancer Conference – Dr. Barbara Melosky |
|
Medical Oncology Session- Chair: Dr. Barb Melosky (BC) |
| 09:10 – 09:55 |
Medical Oncology Keynote Speaker- Dr. Suresh Ramalingam (USA) |
| 09:55 – 10:05 |
Question Period |
| 10:05 – 10:15 |
Betty Rice Award – Presented by Dr. Barb Melosky (BC) |
| 10:15 – 10:35 |
Refreshment Break |
| 10:35 -12:05 |
BREAK OUTS |
| 10:35 – 12:05 |
Radiation Oncology Breakout – Chairs: Dr. Devin Schellenberg (BC) & Dr. Anand Swaminath (ON) |
|
FLASH and New Technologies in Radiation Therapy – Dr. Billy Loo (USA) |
|
Novel Radiosensitizers for Small Cell Lung Cancer: Bench-to-Bedside – Dr. Benjamin Lok (ON) |
|
Did COVID change the Canadian Lung Cancer Landscape? – Dr. Magali Lecavalier (QC) |
|
CAPRI Trials 2.0 (Being Reactive to Proactive) – Dr. Alex Louie (ON) |
|
CCTG and Trial Brainstorming – Dr. Alex Sun (ON) |
|
Panel and Question and Answer Period |
| 10:35 – 12:05 |
Nursing Breakout – Chair: Leslie Markin (BC), Bonnie Leung (BC) |
| 10:35 – 10:55 |
Ageism in Cancer Care – Dr. Kristen Haase (BC) |
| 10:55 -11:15 |
The Role of the CNS in a Multidisciplinary Geriatric Oncology Clinic – Dr. Rana Jin (ON) |
| 11:15 -11:35 |
Exercise in the Prevention of Sarcopenia & Frailty in Older Adult Cancer – Dr. Kristen Campbell (BC) |
| 11:35 – 12:05 |
Question and Answer Period |
| 10:35 – 12:05 |
Medical Oncology Breakout |
| 10:35 -10:55 |
TIGIT – Dr. Peter Ellis (ON) |
| 10:55 -11:15 |
Statistical Trial Design for Rare Molecular Subtypes – Dr. Yu Shyr (USA) |
| 11:15 -11: 350 |
Update in Small Cell Lung Cancer- Dr. Janessa Laskin (BC) |
| 11:35 – 12:05 |
Question and Answer Period |
| 10:35 – 12:05 |
Respiratory and Surgeons Session Breakout – Chair: Dr. Will Lockwood (BC) |
| 10:35 – 11: 35 |
Molecular Biology of Lung Cancer in Never Smokers in Relation to Air Pollution Exposure and Implication in Targeted Therapy- Professor Pan-Chyr Yang (Taiwan) |
| 11:35 – 12:05 |
Question & Answer Period |
| 12:05 – 13:05 |
Lunch |
| 13:10- 14:10 |
Debates |
| 13:10 – 13:30 |
Debate 1: Durvalumab Consolidation for Stage III EGFR Positive NSCLC Post Chemoradiotherapy |
|
Yes- Dr. Aliyah Pabani (AB) |
|
No- Dr. Catherine Labbe (QC) |
|
Voting and Discussion with Audience |
| 13:30 – 13:50 |
Debate 2: Radiation is Now Equivalent to Surgery in Early Stage Non-Small Cell Lung Cancer
Chair: Dr. Alex Sun (ON) |
|
Pro- Joe Chang (USA) |
|
Con- Dr. Basil Nasir (QC) |
|
Voting and Discussion with Audience |
| 13:50 – 14:10 |
Debate 3: Stage II-III Surgically Managed Early Stage NSCLC |
|
Neoadjuvant- Dr. Kevin Jao (QC) |
|
Adjuvant- Dr. Paul Wheatley- Price (ON) |
|
Voting and Discussion with Audience |
| 14:10 – 14:15 |
Closing Remarks – Dr. Barbara Melosky (BC) |
| 18:30 |
Canadian Lung Cancer Conference Closing Dinner |
|
For registered delegates only |
